Impact of Virtual Reality on the Quality of Life of Oncology Patients

Summary

Anxiety, nausea and vomiting are common side effects in paediatric patients receiving chemotherapy. chemotherapy. New evidence supports the efficacy of immersive virtual reality in improving symptoms of anxiety and distress, including nausea and vomiting, in this vulnerable group. This research will evaluate the efficacy of virtual reality in managing anxiety, nausea and vomiting in cancer patients receiving their first line of chemotherapy and will also measure the quality of life of these patients and evaluate patient and nursing staff satisfaction

Eligibility

Inclusion Criteria:

* Chemotherapy-naive patient
* Patient with first-line indication for intravenous cyclic chemotherapy
* Affiliated to a social security system
* Having received full information on the organization of the research and having given free, informed and written consent signed by the participant and the investigator
* Patient understands French or English
* Expected duration of chemotherapy session for the first 3 cycles greater than 30 minutes

exclusion criteria :

* Patient with communication disorders preventing informed consent
* Patient under legal protection (guardianship, curatorship, safeguard of justice)
* Patients suffering from epilepsy
* Severe visual or hearing impairment preventing use of headphones
* Psychiatric pathologies such as delusional disorders, hallucinations or schizophrenia.
* Patients with infections or facial wounds
* Patients with severe claustrophobia
* Patients with pacemakers
* Patients with known cognitive or learning problems,
* Patients with brain tumors or metastases,
* Patients suffering from motion sickness
* Expected duration of chemotherapy session for the first 3 cycles of 30 minutes or less.

Conditions1

Browse More Trials